Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1474-1481

  Hajjar, David P ^a   Gotto, Antonio M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOSE TISSUE; AGE; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR MORTALITY; DISEASE COURSE; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; METABOLIC DISORDER; MOLECULAR MECHANICS; MORBIDITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 84876584919     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.010     Document Type: Short Survey

References (51)

1. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
2. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto, J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, R.J. Glynn JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. D. Steinberg The LDL modification hypothesis of atherogenesis: an update J Lipid Res 50 Suppl 2009 S376 S381
4. P.M. Kris-Etherton, A.H. Lichtenstein, B.V. Howard, D. Steinberg, J.L. Witztum Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism Antioxidant vitamin supplements and cardiovascular disease Circulation 110 2004 637 641
5. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844
6. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
7. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
8. G. Leonarduzzi, P. Gamba, S. Gargiulo, F. Biasi, and G. Poli Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis Free Radic Biol Med 52 2012 19 34
9. A. Taleb, J.L. Witztum, and S. Tsimikas Oxidized phospholipids on apo B-100-containing lipoprotein: a biomarker predicting cardiovascular disease and cardiovascular events Biomark Med 5 2011 673 694
10. A.E. Fraley, G.G. Schwartz, A.G. Olsson, S. Kinlay, M. Szarek, N. Rifai, P. Libby, P. Ganz, J.L. Witztum, S. Tsimikas MIRACL Study Investigators Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial J Am Coll Cardiol 53 2009 2186 2196
11. S.K. Ryu, Z. Mallat, J. Benessiano, A. Tedgui, A.G. Olsson, W. Bao, G.G. Schwartz, S. Tsimikas Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Trial Investigators Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes Circulation 125 2012 757 766
12. P. Libby, P.M. Ridker, G.K. Hansson Leducq Transatlantic Network on Atherothrombosis Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
13. J.A. Leopold, and J. Loscalzo Oxidative risk for atherothrombotic cardiovascular disease Free Radic Biol Med 47 2009 1673 1706
14. R.S. Deeb, B.D. Lamon, and D.P. Hajjar Silent partner in blood vessel homeostasis? Pervasive role of nitric oxide in vascular disease Curr Hypertens Rev 5 2009 273 282
15. T. Münzel, C. Sinning, F. Post, A. Warnholtz, and E. Schulz Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction Ann Med 40 2008 180 196
16. N. Vazzana, F. Santilli, S. Sestil, C. Cuccurullo, and G. Davi Determinants of increased cardiovascular disease in obesity and metabolic syndrome Curr Med Chem 18 2011 5267 5280
17. P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation Circulation 111 2005 1448 1454
18. A. Avignon, M. Hokayem, C. Bisbal, and K. Lambert Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism? Nutrition 28 2012 715 721
19. J.C. Bournat, and C.W. Brown Mitochondrial dysfunction in obesity Curr Opin Endocrinol Diabetes Obes 17 2010 446 452
20. B.D. Lamon, and D.P. Hajjar Inflammation at the molecular interface of atherogenesis: an anthropological journey Am J Pathol 173 2008 1253 1264
21. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880
22. A. Taube, R. Schlich, H. Sell, K. Eckardt, and J. Eckel Inflammation and metabolic dysfunction: links to cardiovascular disease Am J Physiol Heart Circ Physiol 302 2012 H2148 H2165
23. R. Cancello, and K. Clément Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue BJOG 113 2006 1141 1147
24. M. Hulsmans, and P. Holvoet The vicious circle between oxidative stress and inflammation in atherosclerosis J Cell Mol Med 14 2010 70 78
25. B. Gustafson, A. Hammarstedt, C.X. Andersson, and U. Smith Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 2276 2283
26. P. Holvoet, D. De Keyzer, and D.R. Jacobs Jr. Oxidized LDL and the metabolic syndrome Future Lipidol 3 2008 637 649
27. M. Hulsmans, M. Van Dooren, and P. Holvoet Mitochondrial reactive oxygen species and risk of atherosclerosis Curr Atheroscler Rep 14 2012 264 276
28. F. Folli, D. Corradi, P. Fanti, A. Davalli, A. Paez, A. Giaccari, C. Perego, and G. Muscogiuri The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach Curr Diabetes Rev 7 2011 313 324
29. C. Morgantini, A. Natali, B. Boldrini, S. Imaizumi, M. Navab, A.M. Fogelman, E. Ferrannini, and S.T. Reddy Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes 60 2011 2617 2623
30. S. Ragbir, and J.A. Farmer Dysfunctional high-density lipoprotein and atherosclerosis Curr Atheroscler Rep 12 2010 343 348
31. F.J. Pashkow Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Int J Inflam 2011 2011 514623
32. H.H. Szeto, and P.W. Schiller Novel therapies targeting inner mitochondrial membrane-from discovery to clinical development Pharm Res 28 2011 2669 2679
33. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 2011 1410 1422
34. A. Zernecke, and C. Weber Chemokines in the vascular inflammatory response of atherosclerosis Cardiovasc Res 86 2010 192 201
35. S.T. Tarzami Chemokines and inflammation in heart disease: adaptive or maladaptive? Int J Clin Exp Med 4 2011 74 80
36. R.R. Koenen, and C. Weber Chemokines: established and novel targets in atherosclerosis EMBO Mol Med 3 2011 713 725
37. I.F. Charo, and R. Taub Anti-inflammatory therapeutics for the treatment of atherosclerosis Nat Rev Drug Discov 10 2011 365 376
38. E. Maury, and S.M. Brichard Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 314 2010 1 16
39. K.K. Koh, S.M. Park, and M.J. Quon Leptin and cardiovascular disease: response to therapeutic interventions Circulation 117 2008 3238 3249
40. A. Burger-Kentischer, H. Goebel, R. Seiler, G. Fraedrich, H.E. Schaefer, S. Dimmeler, R. Kleemann, J. Bernhagen, and C. Ihling Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis Circulation 105 2002 1561 1566
41. Y. Wang Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2 Br J Pharmacol 165 2012 603 621
42. J.T. Liu, E. Song, A. Xu, T. Berger, T.W. Mak, H.F. Tse, I.K. Law, B. Huang, Y. Liang, P.M. Vanhoutte, and Y. Wang Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition Br J Pharmacol 165 2012 520 531
43. L. Makowski, and G.S. Hotamisligil The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis Curr Opin Lipidol 16 2005 543 548
44. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605
45. K. Kos, and J.P. Wilding Adipokines: emerging therapeutic targets Curr Opin Investig Drugs 10 2009 1061 1068
46. M. Hulsmans, D. De Keyzer, and P. Holvoet MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis FASEB J 25 2011 2525 2527
47. V. Rottiers, and A.M. Näär MicroRNAs in metabolism and metabolic disorders [Erratum appeared in Nat Rev Mol Cell Biol 2012, 13(5)] Nat Rev Mol Cell Biol 13 2012 239 251
48. J. Sacco, and K. Adeli MicroRNAs: emerging roles in lipid and lipoprotein metabolism Curr Opin Lipidol 23 2012 220 225
49. L.J. Chen, S.H. Lim, Y.T. Yeh, S.C. Lien, and J.J. Chiu Roles of microRNAs in atherosclerosis and restenosis J Biomed Sci 19 2012 79
50. F. Fleissner, V. Jazbutyte, J. Fiedler, S.K. Gupta, X. Yin, Q. Xu, P. Galuppo, S. Kneitz, M. Mayr, G. Erti, J. Bauersachs, and T. Thum Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21- dependent mechanism Circ Res 107 2010 138 143
51. G. Zhuang, C. Meng, X. Guo, P.S. Cheruku, L. Shi, H. Xu, H. Li, G. Wang, A.R. Evans, S. Safe, C. Wu, and B. Zhou A novel regulator of macrophage activation: miR-223 in obesity associated adipose tissue inflammation Circulation 125 2012 2892 2903